NOV 17, 2021 10:00 AM PST

Device Helps Study How COVID-19 Infection Affects The Intestines

WRITTEN BY: Ryan Vingum

The textbook symptoms of COVID-19 infection are often respiratory ones; at least, that’s what most people focus on. We’re all familiar with the characteristic dry cough and difficulty breathing that can accompany more moderate to severe cases. However, COVID-19 infection also causes a range of other symptoms, including gastrointestinal (GI) symptoms like diarrhea and nausea, which can have serious consequences. One study found that up to 25% of COVID-19 patients at one clinic experienced some kind of GI symptom, and patients who experienced diarrhea, specifically, were more likely to die or end up in intensive care.

Researchers have found that gut cells have high levels of ACE2 receptor proteins, the proteins that the SARS-CoV-2 uses to enter cells, making the gut a prime location for infection. However, studying the gut in animals is expensive and not entirely descriptive of what happens in humans, making it challenging to observe how infection affects the gut and test new drugs to treat these infections. To counter this challenge, researchers have developed a sort of “intestine in a chip” device that would allow researchers to study different ways COVID-19 affects the gut and the effectiveness of different treatments.

The device, which is described in detail in Frontiers in Pharmacology, is about the size of a USB and is designed to “model” the human gut. The device uses 2 “channels,” lined with endothelial cells and intestinal cells, and is designed to mimic the peristaltic activity (wave-like contractions) of the gut. 

In the paper, researchers described two phenomena. First, researchers found that epithelial tissue (surface tissue) became damaged or “leaky” following infection, which means gaps in the intestinal wall are forming and allowing contents of the gut to spill into the bloodstream. Second, when testing remdesivir as a possible treatment, researchers found that it did not help the infection and actually worsened damage to the gut. Remdesivir is an antiviral drug that was granted emergency FDA approval in 2020. Instead, researchers were able to test other drugs through their chip, and found that the drug Nafamostat (a serine protease inhibitor) helped reduce viral loads. 

Sources: Medgadget; Indian Journal of Gastroenterology; Frontiers in Pharmacology 

About the Author
  • Science writer and editor, with a focus on simplifying complex information about health, medicine, technology, and clinical drug development for a general audience.
You May Also Like
NOV 25, 2021
Cell & Molecular Biology
Analyzing Cells With Virtual Reality
NOV 25, 2021
Analyzing Cells With Virtual Reality
Research tools that are used to analyze gene expression have gotten cheaper, faster, and incredibly complex. An entire h ...
DEC 01, 2021
Neuroscience
Researchers Use the Internet to Control Animal Brains Remotely
DEC 01, 2021
Researchers Use the Internet to Control Animal Brains Remotely
Researchers can remotely control the brain circuits of multiple animals at the same time using the internet. The corresp ...
DEC 01, 2021
Space & Astronomy
The Two Closest Supermassive Black Holes
DEC 01, 2021
The Two Closest Supermassive Black Holes
A team of international researchers have observed the center of galaxy NGC 7727 and found two supermassive black holes ( ...
DEC 06, 2021
Technology
Solar-Powered Robots That Could Clean Up Oil Spills
DEC 06, 2021
Solar-Powered Robots That Could Clean Up Oil Spills
Oil spills at sea can be a devastating consequence of offshore drilling for fossil fuels. They can affect local plants a ...
JAN 04, 2022
Clinical & Molecular DX
Smart Stitches Track Surgical Wound Healing
JAN 04, 2022
Smart Stitches Track Surgical Wound Healing
  As early as 3000 BC, ancient Egyptians described the use of sutures for drawing open wounds shut to facilitate he ...
JAN 05, 2022
Technology
A Digital Therapeutic for IBS Pain Management?
JAN 05, 2022
A Digital Therapeutic for IBS Pain Management?
Digital therapeutics (DTx) continue to rise in prevalence and scientific efficacy. While technology is nothing new in he ...
Loading Comments...